Zühlke Ventures
Corporate VCZurich · Pre-Seed–Series A · 2 people tracked
Investment thesis
Zühlke Ventures invests exclusively in early-stage HealthTech startups, aiming to recognize potential early, take minority stakes, and support portfolio companies over a 5-8 year horizon. It focuses primarily on Switzerland and Europe, with complementary interests in the US. Beyond capital, it offers access to Zühlke Group's management and technology know-how through a cooperative partnership model. Initial investments range from CHF 150k to 250k per startup.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from public directories
What they invest in
from 14 of 19 portfolio companiesMedical Devices ×11Healthtech ×9Digital Health ×6AI & Machine Learning ×2Biotech ×2Deep Tech ×2Hardware ×2SaaS ×2
HQs:Switzerland×7United States×5Germany×1
Investments · 19 tracked
founders shown can be your intro pathBy year:2020 · 12019 · 12 dated
HealthtechMedical DevicesLos Gatos, US
Richard Ginn(Chief Technology Officer)inKevin Williamson(Chief Financial Officer)Steven Foster(Chief Executive Officer and President)Steven Van Dick(Executive Officer)James Huie(Executive Officer)Kal Mentak(Director)
Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases.
Digital HealthHealthtechMedical Devices
Charvi Shetty(Chief Executive Officer)inInderjit Jutla(Chief Scientific Officer)
Co-investorsBlue Bear VenturesGood Growth CapitalMatrixRho Capital PartnersRho Ventures
Co-investorsKickfund
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
Co-investors415 Capital4see VenturesPrivilège Ventures
Droplette makes a patented device that converts skincare serums into a fine mist designed to penetrate the skin barrier, sold alongside serum capsules such as its Collagen Boosting Hydrofiller.
ConsumerDirect to ConsumerWellness & FitnessBoston, US
Rathi Srinivas(Executive Officer, Director)inMadhavi Gavini(Executive Officer, Director)
BoardSanto Politi(Director)in
Co-investorsBantam GroupSpark CapitalVisible Ventures
DSwiss (operating as SecureSafe) builds Swiss-hosted document security software offering encrypted storage, document exchange, access control, and compliance-ready architecture for organisations handling sensitive financial, legal, and personnel data, as well as individuals.
CybersecurityEnterprise SoftwareSaaSSwitzerland, CH
Andreas(CEO)inGiacomo(CTO)inVeselina(VP Product)inBurkhart(CFO)in
evismo provides diagnostic services using sensor technology to detect cardiac arrhythmias, stress, and sleep apnea for general practitioners and specialists.
Digital HealthHealthtechMedical Devices
Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment.
Digital HealthHealthtechMedical DevicesSwitzerland, CH
Hystrix Medical operates a source-to-contract procurement platform for the healthcare sector, connecting buyers and sellers to manage sourcing, tendering, negotiations, and contract signing (with DocuSign integration) for medical and non-medical spend.
B2B MarketplacesHealthtechSaaS
Co-investorsSICTICStartAngels Network
Indivi is a medical technology company developing tools for precision and personalised medicine in neuroscience research and development, including Bring Your Own Device (BYOD) technology.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Cristina Granziera(Co-CEO)Ludwig Kappos(Co-CEO)
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)
BoardJosh Baltzell(Director)inJan Garfinkle(Director)in
Co-investorsAphelion CapitalArboretum VenturesScientific Health DevelopmentOrbiMed
Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes.
BiotechDeep TechHardwareMedical DevicesLausanne, CH
Thomas Eaton(Founder & CEO)inYann Pierson(Founder & CTO)inCaroline Boudousquié(Head of Solutions)inOlivier Waridel(Head of Operations)in
Co-investorsLifeX VenturesVerve Ventures
Lunaphore provides spatial biology technology for research labs, enabling multiplexed immunohistochemistry (IHC) analysis with existing antibodies.
BiotechDeep TechMedical DevicesLausanne, CH
Co-investorsOCCIDENTPolytech Ecosystem Ventures
Exit: acquired by Broadridge in 2017.
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)in
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedTreo Ventures, LlcBridge BankSandbox Clinical Ventures+1 more
PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Patrick Kessel(Co-founder, CEO & board member)inDr. Serife Kucur(Co-founder & CTO)Prof. Raphael Sznitman(Co-Founder & board member)Serife Kucur Ergunay(Co-founder, CTO & board member)Raphael Sznitman(Co-founder & board member)inKevin Gillmann(Chief Medical Officer)in
Co-investorsSICTIC
Exit: acquired by Sentec in 2018.
Exits · 3
IPOs and acquisitions across the tracked portfolioTenon MedicalNASDAQ: TNONMessage Automationacq. by BroadridgeSwisstomacq. by Sentec
Portfolio news
latest coverage across their companiesTenon Medical · investing.com · Aug 24, 2026
Koya Medical · briefglance.com · May 26, 2026
Noctrix Health · nasdaqprivatemarket.com · Apr 3, 2026
Aluna · apgcapitalmarkets.com · Sep 28, 2025
Frequently asked questions
- How many investments has Zühlke Ventures made?
- Zühlke Ventures has 19 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does Zühlke Ventures invest at?
- Zühlke Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Zühlke Ventures's typical check size?
- Zühlke Ventures typically writes checks of $165K – $275K.
- What sectors does Zühlke Ventures focus on?
- Zühlke Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Zühlke Ventures located?
- Zühlke Ventures is headquartered in Zurich, CH.
- Does Zühlke Ventures lead rounds?
- Zühlke Ventures typically participates in rounds rather than leading them.
- Who does Zühlke Ventures co-invest with?
- Zühlke Ventures most often shares deals with SICTIC, StartAngels Network, Arboretum Ventures, among 23 tracked co-investors.
Media · Podcasts & interviews
from their channelAI-assisted software archaeology: turning legacy guesswork into evidence
Zühlke Group
Are leaders deploying AI faster than they can effectively govern it? With Zahra Shah
Zühlke Group
Is it possible for ‘tech for good’ to exist within a for-profit model? With Jim Fruchterman
Zühlke Group
Resilience Rewired: Inside Swissgrid's move to autonomous drone inspection
Zühlke Group
Resilienz neu gedacht: Wie Swissgrid autonome Drohneninspektionen realisiert
Zühlke Group
Is irrational AI making our decision-making worse? With Stephanie Antonian
Zühlke Group
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.